Cornerstone Therapeutics Inc. (NASDAQ:CRTX)
CAPS Rating:
A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.
RSS Headlines
Fool UK
Recs
They have had huge success with their asthma meds and they have some new ones in late stages of trials. This company has no where to go but up.